As HIV diagnoses continue increasing in metro Atlanta, the number of dollars for research and treatment is going down.
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...
This guide responds to a growing demand for practical, adaptable methods to project the full resource needs of NSPs, offering tools transferable to broader health planning and a YouTube playlist with ...